New lifestyle program aims to tame type 2 diabetes with less medication

NCT ID NCT05766735

Recruiting now Disease control Sponsor: Chiara Fabris, PhD Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a program called Glycemic Excursion Minimization (GEM) for people newly diagnosed with type 2 diabetes. Participants use a continuous glucose monitor to see how food and activity affect their blood sugar, then make personalized changes. The goal is to lower blood sugar and reduce the need for diabetes medication compared to routine care alone. The trial enrolls 200 adults and follows them for over a year.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Glycemic Excursion Minimization (GEM) program
What this could lead to: If successful, this program could help people with early type 2 diabetes better control their blood sugar with less medication, potentially reducing long-term complications.
What could go wrong: This is a behavioral intervention, not a drug, so results depend heavily on participant adherence. The trial is relatively small (200 people) and early-stage, so findings may not apply to everyone with type 2 diabetes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 2 DIABETES

Contacts and locations

Locations

University of Colorado Department of Family Medicine
RECRUITING

Aurora, Colorado, 80045, United States
University of Virginia Center for Diabetes Technology
RECRUITING

Charlottesville, Virginia, 22903, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.